| 73.82 Data as of May 23 |  -0.80 / -1.07%Today’s Change | 51.20 Today|||52-Week Range 75.73 | +16.62% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $178.7B |
Company Description
Novartis AG manufactures and markets health care and nutritional products. It provides innovative healthcare solutions and offers innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The company operates through five segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics and Consumer Health. The Pharmaceuticals segment provides innovative patent protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals and vision care products. The Sandoz segment provides generic pharmaceuticals. The Vaccines and Diagnostics segment provides human vaccines and blood testing diagnostics. The Consumer Health segment contains two divisions, such as OTC and Animal Health, which manufactures, distributes and sells capabilities. Novartis was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Employees
Shareholders
| Other institutional | 5.12% |
| Mutual fund holders | 3.88% |
| Individual stakeholders | -- |
Top Executives
| Joseph Jimenez, MBA | Chief Executive Officer |
| Harry Kirsch | Chief Financial Officer |
| Kevin J. Buehler | Member-Executive Board |
| David R. Epstein, MBA | Member-Executive Board |
| Mark C. Fishman, MD | Member-Executive Board |
.
